Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

被引：0
|
作者：
Arzu Soybilgic
Karen B Onel
Tammy Utset
Kenneth Alexander
Linda Wagner-Weiner
机构：
[1] University of Illinois,
[2] University of Chicago,undefined
来源：
Pediatric Rheumatology | / 11卷
关键词：
Human papillomavirus; Lupus; Safety; Immunogenicity; Pediatric; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study
    Fan, Renfeng
    Huang, Xiaoyuan
    Nian, Xuanxuan
    Ou, Zhiqiang
    Zhou, Jian
    Zhang, Jiayou
    Zeng, Peiyu
    Zhao, Wei
    Deng, Jinglong
    Chen, Wei
    Chen, Shaomin
    Duan, Kai
    Chen, Yingshi
    Li, Xinguo
    Zhang, Jikai
    Yang, Xiaoming
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01) : 1 - 9
  • [32] SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1180
  • [33] Human Papillomavirus Vaccine in Patients with Systemic Lupus Erythematosus
    Pellegrino, Paolo
    Carnovale, Carla
    Perrone, Valentina
    Salvati, Dionigi
    Gentili, Marta
    Antoniazzi, Stefania
    Clementi, Emilio
    Radice, Sonia
    EPIDEMIOLOGY, 2014, 25 (01) : 155 - 156
  • [34] Safety and Immunogenicity of Quadrivalent Human Papilloma Virus (qHPV) Vaccine (Gardasil®) in Systemic Lupus Erythematous (SLE), Phase I Trial Completion
    Dhar, J. Patricia
    Essenmacher, Lynnette
    Dhar, Renee
    Magee, Ardella
    Ager, Joel
    Sokol, Robert
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [35] Safety and Immunogenicity of the Quadrivalent HPV Vaccine in Japanese Boys: a Phase 3, Open-Label Study
    Murata, Shinya
    Takeuchi, Yuzuru
    Yamanaka, Kou
    Hayakawa, Jun
    Yoshida, Masashige
    Yokokawa, Ruriko
    Wakana, Akira
    Sawata, Miyuki
    Tanaka, Yoshiyuki
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2019, 72 (05) : 299 - 305
  • [36] Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Administered Concomitantly with a 23-Valent Pneumococcal Polysaccharide Vaccine in Adults Aged 60 Years and Older
    Zhu, Zhongkui
    Sun, Jianwen
    Xie, Yan
    Lu, Xi
    Tang, Wanqin
    Zhao, Yanwei
    Shen, Lu
    Liu, Huaxian
    Yu, Yang
    Zhou, Siliang
    Huo, Liqun
    Jiao, Peng
    Jiang, Xiaoli
    VACCINES, 2024, 12 (08)
  • [37] Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
    Moreira, E. D.
    Giuliano, A. R.
    de Hoon, J.
    Iversen, O. -E.
    Joura, E. A.
    Restrepo, J.
    Van Damme, P.
    Vandermeulen, C.
    Ellison, M. C.
    Krick, A.
    Shields, C.
    Heiles, B.
    Luxembourg, A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) : 396 - 403
  • [38] Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus
    Mormile, Ilaria
    Della Casa, Francesca
    Petraroli, Angelica
    Furno, Alessandro
    Granata, Francescopaolo
    Portella, Giuseppe
    Rossi, Francesca Wanda
    de Paulis, Amato
    VACCINES, 2022, 10 (08)
  • [39] Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico
    Arredondo, Jose Luis
    Martinez, Sandra Maria Villagomez
    Morales, Maria Concepcion
    Meyer, Stephanie
    Toh, Myew-Ling
    Zocchetti, Celine
    Vigane, Claire
    Mascarenas, Cesar
    VACCINE, 2021, 39 (25) : 3388 - 3396
  • [40] Quadrivalent HPV vaccine prevented HPV infection and external genital lesions in boys and men 16 to 26 years of age
    Bender, Bradley S.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (10)
12345